XML 138 R104.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share-Based Compensation Share-Based Compensation - Restricted Stock and Performance Shares (Details) - $ / shares
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 18.12 $ 18.89
Ending balance, Weighted Average Grant Date Fair Value $ 18.16 $ 18.12
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 177,210  
Granted, Number of Share Units Outstanding 68,710  
Vested, Number of Share Units Outstanding 63,748  
Forfeited, Number of Share Units Outstanding (10,232)  
Ending balance, Number of Share Units Outstanding 171,940 177,210
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 48.90  
Granted, Weighted Average Grant Date Fair Value 56.73  
Vested, Weighted Average Grant Date Fair Value 44.92  
Forfeited, Weighted Average Grant Date Fair Value 54.33  
Ending balance, Weighted Average Grant Date Fair Value $ 53.18 $ 48.90
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 175,069  
Granted, Number of Share Units Outstanding 61,740  
Net increase due to estimated performance, Number of Share Units Outstanding (22,578)  
Vested, Number of Share Units Outstanding 92,991  
Ending balance, Number of Share Units Outstanding 121,240 175,069
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 48.95  
Granted, Weighted Average Grant Date Fair Value 55.54  
Net increase due to estimated performance, Weighted Average Grant Date Fair Value 54.39  
Vested, Weighted Average Grant Date Fair Value 45.01  
Ending balance, Weighted Average Grant Date Fair Value $ 54.32 $ 48.95